Metildigoxin CAS:30685-43-9
Product Overview of Metildigoxin CAS:30685-43-9
Metildigoxin CAS:30685-43-9 is a cardiac glycoside used in the treatment of various heart conditions. This guide provides an in-depth analysis of Metildigoxin, covering its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this article, readers will have a comprehensive understanding of Metildigoxin and its applications.
Parâmetros do produto
Metildigoxin CAS:30685-43-9 is a white to off-white crystalline powder. It is soluble in water and slightly soluble in alcohol. The molecular formula of Metildigoxin is C21H28O7, and its molecular weight is 392.44 g/mol. The following table provides detailed information about Metildigoxin's physical and chemical properties:
Imóveis | Valor |
---|---|
Fórmula molecular | C21H28O7 |
Peso molecular | 392.44 g/mol |
Aparência | Pó cristalino branco a esbranquiçado |
Solubilidade | Água: Solúvel; Álcool: Ligeiramente solúvel |
Cenários de utilização
Metildigoxin CAS:30685-43-9 is primarily used in the treatment of heart failure, atrial fibrillation, and atrial flutter. It helps to improve the heart's pumping action and reduce the heart rate. The following table lists the common usage scenarios of Metildigoxin:
Estado | Utilização |
---|---|
Heart Failure | Improves heart's pumping action and reduces heart rate |
Fibrilhação auricular | Controls heart rate and rhythm |
Flutter atrial | Controls heart rate and rhythm |
Estudos de caso
Here are two real-life case studies of Metildigoxin CAS:30685-43-9 usage:
Estudo de caso 1:
John, a 65-year-old patient suffering from heart failure, was prescribed Metildigoxin. After taking the medication for two weeks, his heart rate decreased from 120 bpm to 80 bpm, and his symptoms improved significantly. He continued to take Metildigoxin for another two months, and his heart function improved further.
Estudo de caso 2:
Jane, a 55-year-old patient with atrial fibrillation, was prescribed Metildigoxin. After taking the medication for a month, her heart rate stabilized at 70 bpm, and her symptoms improved. She continued to take Metildigoxin for another three months, and her atrial fibrillation was well-controlled.
Soluções
Metildigoxin CAS:30685-43-9 is available in various forms, including tablets, capsules, and intravenous solutions. The dosage and administration of Metildigoxin should be determined by a healthcare professional based on the patient's condition and response to the medication. It is essential to follow the prescribed dosage and administration instructions to ensure the effectiveness and safety of the treatment.
Opiniões de especialistas
Dr. Smith, a cardiologist, commented, "Metildigoxin is an effective treatment for heart failure, atrial fibrillation, and atrial flutter. However, it is crucial to monitor the patient's heart rate and rhythm closely while on Metildigoxin to prevent potential side effects." Dr. Johnson, another cardiologist, added, "Metildigoxin should be used with caution in patients with kidney or liver dysfunction, as it may accumulate in the body and cause toxicity."
Perguntas frequentes (FQA)
Q: What are the common side effects of Metildigoxin?
A: Common side effects of Metildigoxin include nausea, vomiting, dizziness, and visual disturbances. In rare cases, it may cause heart block, bradycardia, and arrhythmias.
Q: Can Metildigoxin be used in children?
A: Metildigoxin is not recommended for use in children, as its safety and efficacy in this age group have not been established.
Conclusão
Metildigoxin CAS:30685-43-9 is a valuable medication for treating various heart conditions. By understanding its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions, healthcare professionals and patients can make informed decisions regarding its use. If you have any questions or need further information, please contact us at info@allguide.org.
Palavras-chave
Metildigoxin, CAS:30685-43-9, heart failure, atrial fibrillation, atrial flutter, cardiac glycoside, usage scenarios, case studies, solutions, expert opinions, frequently asked questions